CLINICAL_TRIALS
withdrawal
· 2016-09-16
Clinical Trial Update: Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease [Phase 4]
Summary
Phase 4 trial evaluating the effectiveness and safety of treatments for spondyloarthritis related to inflammatory bowel disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alberta | Conditions: Spondyloarthritis, Crohn's Disease | Phase 4 | Status: WITHDRAWN